Journal
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Volume 9, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.796686
Keywords
circCRIM1; HCC; MiR-378a-3p; Skp2; proliferation; angiogenesis
Categories
Funding
- National Natural Science Foundation of China [81971504]
- Post-Doctoral Special Foundation of China [2020M670065ZX]
- Post-Doctoral Foundation of Jiangsu Province [2020Z021]
- Postgraduate Research and Practice Innovation Program of Jiangsu Province [SJCX20_0474]
- Changzhou Society Development Funding [CE20205038]
- The lifting Project of Young Scientific and Technological Talents in Changzhou
Ask authors/readers for more resources
CircCRIM1 is upregulated in hepatocellular carcinoma (HCC) and is associated with poor prognosis, enhancing cell proliferation and angiogenesis. It promotes HCC progression via the miR-378a-3p/SKP2 axis.
Mounting evidence has demonstrated that circular RNAs have an important function in tumorigenesis and cancer evolvement. CircCRIM1 has been shown to be a poor prognostic element in multiple human malignancies. However, the clinical significance and mechanism of circCRIM1 in hepatocellular carcinoma (HCC) is still unclear. The present study confirmed the expression level of circCRIM1 using quantitative real-time PCR. In addition, circCRIM1 siRNA and overexpression vectors were used for transfection into LM3 or Huh7 cells to down- or up-regulate the expression of circCRIM1. In vitro and in vivo experiments were performed to explore the function of circCRIM1 in HCC. RNA pull-down, RNA immunoprecipitation, fluorescent in situ hybridization, and luciferase reporter assays were conducted to confirm the relationship between miR-378a-3p and circCRIM1 or S-phase kinase-associated protein 2 (SKP2) in HCC. Then, circCRIM1 was up-regulated in HCC and its expression level was significantly associated with poor prognosis and clinicopathologic characteristics. CircCRIM1 enhanced the proliferation and angiogenesis of HCC cells in vitro and promoted xenograft growth in vivo. Moreover, circCRIM1 upregulated the expression of SKP2 by functioning as a sponge for miR-378a-3p. These findings suggest that circCRIM1 boosts the HCC progression via the miR-378-3p/SKP2 axis and may act as a crucial epigenetic therapeutic molecule target in HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available